MA45574A - Procédés de traitement de lésions ou de pathologies liées à un dème du snc - Google Patents
Procédés de traitement de lésions ou de pathologies liées à un dème du sncInfo
- Publication number
- MA45574A MA45574A MA045574A MA45574A MA45574A MA 45574 A MA45574 A MA 45574A MA 045574 A MA045574 A MA 045574A MA 45574 A MA45574 A MA 45574A MA 45574 A MA45574 A MA 45574A
- Authority
- MA
- Morocco
- Prior art keywords
- ema
- injuries
- cns
- procedures
- treatment
- Prior art date
Links
- 230000006378 damage Effects 0.000 title 1
- 238000000034 method Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/451—Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Heart & Thoracic Surgery (AREA)
- Neurology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Dermatology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562238461P | 2015-10-07 | 2015-10-07 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA45574A true MA45574A (fr) | 2019-05-15 |
Family
ID=58488580
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA045574A MA45574A (fr) | 2015-10-07 | 2016-10-07 | Procédés de traitement de lésions ou de pathologies liées à un dème du snc |
Country Status (15)
| Country | Link |
|---|---|
| US (4) | US20180280325A1 (enExample) |
| EP (1) | EP3359162B1 (enExample) |
| JP (4) | JP7349786B2 (enExample) |
| KR (2) | KR102681027B1 (enExample) |
| CN (2) | CN108348534A (enExample) |
| AU (3) | AU2016335767B2 (enExample) |
| BR (1) | BR112018006925A2 (enExample) |
| CA (1) | CA3001321A1 (enExample) |
| EA (1) | EA201890893A1 (enExample) |
| ES (1) | ES2940669T3 (enExample) |
| HK (1) | HK1257542A1 (enExample) |
| IL (1) | IL258509B2 (enExample) |
| MA (1) | MA45574A (enExample) |
| MX (1) | MX392466B (enExample) |
| WO (1) | WO2017062765A1 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2872012C (en) | 2012-05-08 | 2017-06-20 | Aeromics, Llc | New methods |
| CN106163506A (zh) | 2013-11-06 | 2016-11-23 | 埃罗米克斯公司 | 新配方 |
| MA45574A (fr) * | 2015-10-07 | 2019-05-15 | Biogen Chesapeake Llc | Procédés de traitement de lésions ou de pathologies liées à un dème du snc |
| WO2020041905A1 (en) * | 2018-08-31 | 2020-03-05 | The University Of British Columbia | Methods for identifying compounds suitable for treatment of central nervous system trauma and uses of those compounds |
| EP3962466A4 (en) * | 2019-05-02 | 2023-01-25 | Biogen Chesapeake LLC | METHODS OF TREATMENT OF PERSONS WITH CONtusions Of The Central Nervous System |
| JP7781851B2 (ja) * | 2020-07-17 | 2025-12-08 | 上海森輝医薬有限公司 | スルホニル尿素誘導体及びその医薬用途 |
| US12251388B1 (en) * | 2024-05-09 | 2025-03-18 | Remedy Pharmaceuticals, Inc. | Methods of treating ischemic stroke at risk for cerebral or cerebellar edema |
| WO2025212154A1 (en) * | 2024-04-05 | 2025-10-09 | Remedy Pharmaceuticals, Inc. | Methods of treating ischemic stroke at risk for cerebral or cerebellar edema |
| WO2025212189A1 (en) * | 2024-04-05 | 2025-10-09 | Remedy Pharmaceuticals, Inc. | Methods of treating ischemic stroke at risk for cerebral or cerebellar edema using a sur1-trpm4 channel inhibitor |
| WO2025212155A1 (en) * | 2024-04-05 | 2025-10-09 | Remedy Pharmaceuticals, Inc. | Methods of treating ischemic stroke with large vessel occlusion using a sur1-trpm4 channel inhibitor |
| US12251389B1 (en) | 2024-04-22 | 2025-03-18 | Remedy Pharmaceuticals, Inc. | Methods of treating ischemic stroke at risk for cerebral or cerebellar edema |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5856360A (en) | 1996-05-03 | 1999-01-05 | Children's Hospital Medical Center | Pharmaceutical method for the treatment of severe blood loss and for the inhibition or treatment of hemorrhagic shock |
| JP4485806B2 (ja) | 2002-03-20 | 2010-06-23 | ユニヴァーシティ オブ メリーランド，ボルチモア | 神経系細胞の非選択的陽イオンチャネルおよび脳腫脹を治療する方法 |
| US8980952B2 (en) * | 2002-03-20 | 2015-03-17 | University Of Maryland, Baltimore | Methods for treating brain swelling with a compound that blocks a non-selective cation channel |
| US20050246000A1 (en) * | 2004-05-03 | 2005-11-03 | Seacoast Technologies, Inc. | Cooled craniectomy |
| CA2691199C (en) | 2007-06-22 | 2017-09-12 | Marc J. Simard | Inhibitors of ncca-atp channels for therapy |
| PL2868315T3 (pl) * | 2007-12-04 | 2018-06-29 | Biogen Chesapeake Llc | Udoskonalone preparaty i sposoby liofilizacji oraz uzyskiwane liofilizaty |
| JP6188021B2 (ja) * | 2010-07-19 | 2017-08-30 | バイオジェン チェサピーク エルエルシー | グリブリドおよび他の薬剤の静脈内投与方法 |
| MA45574A (fr) * | 2015-10-07 | 2019-05-15 | Biogen Chesapeake Llc | Procédés de traitement de lésions ou de pathologies liées à un dème du snc |
-
2016
- 2016-10-07 MA MA045574A patent/MA45574A/fr unknown
- 2016-10-07 KR KR1020187012950A patent/KR102681027B1/ko active Active
- 2016-10-07 CN CN201680066630.6A patent/CN108348534A/zh active Pending
- 2016-10-07 EP EP16854422.9A patent/EP3359162B1/en active Active
- 2016-10-07 US US15/763,932 patent/US20180280325A1/en not_active Abandoned
- 2016-10-07 BR BR112018006925A patent/BR112018006925A2/pt not_active Application Discontinuation
- 2016-10-07 ES ES16854422T patent/ES2940669T3/es active Active
- 2016-10-07 KR KR1020247021781A patent/KR20240105519A/ko not_active Ceased
- 2016-10-07 CA CA3001321A patent/CA3001321A1/en active Pending
- 2016-10-07 JP JP2018517841A patent/JP7349786B2/ja active Active
- 2016-10-07 AU AU2016335767A patent/AU2016335767B2/en active Active
- 2016-10-07 CN CN202211412393.8A patent/CN115737816A/zh active Pending
- 2016-10-07 EA EA201890893A patent/EA201890893A1/ru unknown
- 2016-10-07 HK HK18116503.6A patent/HK1257542A1/zh unknown
- 2016-10-07 MX MX2018004286A patent/MX392466B/es unknown
- 2016-10-07 IL IL258509A patent/IL258509B2/en unknown
- 2016-10-07 WO PCT/US2016/055988 patent/WO2017062765A1/en not_active Ceased
-
2021
- 2021-02-16 JP JP2021022562A patent/JP2021073317A/ja not_active Withdrawn
- 2021-09-29 US US17/488,591 patent/US11951085B2/en active Active
-
2022
- 2022-11-28 AU AU2022279369A patent/AU2022279369B2/en active Active
-
2023
- 2023-02-13 JP JP2023020327A patent/JP7592768B2/ja active Active
-
2024
- 2024-03-04 US US18/595,205 patent/US20240216309A1/en active Pending
- 2024-08-23 JP JP2024142687A patent/JP2024164167A/ja active Pending
- 2024-09-30 US US18/902,504 patent/US20250017880A1/en active Pending
-
2025
- 2025-04-14 AU AU2025202620A patent/AU2025202620A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA45574A (fr) | Procédés de traitement de lésions ou de pathologies liées à un dème du snc | |
| EP3426250A4 (en) | TREATMENT PROCEDURE | |
| EP3303413A4 (en) | PROCESS FOR THE PREPARATION OF SUGAMMADEX AND INTERMEDIATE PRODUCTS THEREOF | |
| EP3377068A4 (en) | COMBINATION THERAPY OF TETRACYCLIC CHINOLONANALOGES FOR THE TREATMENT OF CANCER | |
| EP3388004A4 (en) | Treatment instrument | |
| EP3331527A4 (en) | METHOD FOR TREATING DEVELOPMENT DISORDERS WITH PIPRADROL | |
| MA43872A (fr) | Procédé de traitement d'une glomérulopathie à c3 | |
| EP3398960A4 (en) | METHOD FOR PRODUCING SERMAGLUTIDE | |
| EP3374502A4 (en) | METHOD FOR THE TREATMENT OF CORNEAL DYSTROPHIES | |
| EP3515857A4 (en) | UNIVERSAL DISPENSER MONITOR | |
| EP3351188A4 (en) | ENDOSCOPE TREATMENT INSTRUMENT | |
| EP3421503A4 (en) | SUGAMMADEX MANUFACTURE AND CLEANING PROCEDURE | |
| EP3351189A4 (en) | ENDOSCOPE TREATMENT INSTRUMENT | |
| EP3351186A4 (en) | ENDOSCOPE TREATMENT INSTRUMENT | |
| EP3351187A4 (en) | ENDOSCOPE TREATMENT INSTRUMENT | |
| EP3409744A4 (en) | SURFACE TREATMENT AGENT | |
| MA42999A (fr) | Polythérapie pour le traitement de malignités | |
| EP3341391A4 (en) | COMPOSITIONS AND METHODS OF PAIN TREATMENT | |
| EP3328374A4 (en) | GLUTAMINANTAGONISTS FOR THE TREATMENT OF COGNITIVE DEFICITES | |
| EP3455188C0 (de) | Verfahren zur behandlung von schlacke | |
| EP3431566A4 (en) | SURFACE TREATMENT AGENT | |
| EP3335041A4 (en) | BIOMARKER FOR THE TREATMENT OF ALOPECIA AREATA | |
| EP3334432A4 (en) | CERDULATINIB FOR THE TREATMENT OF MYELOMA | |
| EP3439657A4 (en) | METHOD FOR TREATING DEVELOPMENT DISTURBANCES USING PIPRADROL | |
| HUE064604T2 (hu) | Menotropin meddõség kezelésére |